These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011
|
|
OR
|
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
|
|
Non-accelerated Filer
|
[ ]
|
Smaller Reporting Company
|
[X]
|
|
|
(Do not check if smaller reporting company)
|
||||
|
|
Page
|
|
|
PART I. FINANCIAL INFORMATION
|
||
|
|
||
|
ITEM 1.
|
Financial Statements.
|
3
|
|
|
||
|
ITEM 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
11
|
|
|
||
|
ITEM 3.
|
Quantitative and Qualitative Disclosures about Market Risk.
|
13
|
|
|
||
|
ITEM 4.
|
Controls and Procedures.
|
13
|
|
|
||
|
|
||
|
PART II. OTHER INFORMATION
|
||
|
|
||
|
ITEM 1A.
|
Risk Factors.
|
14
|
|
|
||
|
ITEM 6.
|
Exhibits.
|
14
|
|
September 30,
2011
$
|
December 31,
2010
$
|
|
|
ASSETS
|
||
|
Current Assets
|
||
|
Cash
|
481,005
|
33,034
|
|
Prepaid expenses and deposits
|
9,542
|
–
|
|
Total Current Assets
|
490,547
|
33,034
|
|
Intangible assets
|
82,538
|
–
|
|
Total Assets
|
573,085
|
33,034
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
||
|
Current Liabilities
|
||
|
Accounts payable and accrued liabilities
|
9,362
|
30,567
|
|
Accounts payable and accrued liabilities – related
|
4,007
|
–
|
|
Due to related parties
|
325,000
|
11,965
|
|
Notes payable
|
–
|
139,600
|
|
Total Current Liabilities
|
338,369
|
182,132
|
|
Long-term note payable, net of beneficial conversion
|
484,542
|
–
|
|
Total Liabilities
|
822,911
|
182,132
|
|
Stockholders’ Deficit
|
||
|
Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: nil and nil preferred shares, respectively
|
–
|
–
|
|
Class A Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: 7,500,000 and nil preferred shares, respectively
|
7,500
|
–
|
|
Common Stock
Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share
Issued and outstanding: 347,380,000 and 538,200,000 common shares
|
347,380
|
538,200
|
|
Additional paid-in capital
|
(561,143)
|
(518,801)
|
|
Deficit accumulated during the development stage
|
(43,563)
|
(168,497)
|
|
Total Stockholders’ Deficit
|
(249,826)
|
(149,098)
|
|
Total Liabilities and Stockholders’ Deficit
|
573,085
|
33,034
|
|
For the Three
Months Ended
September 30,
2011
$
|
For the Three
Months Ended
September 30,
2010
$
|
For the Nine
Months Ended
September 30,
2011
$
|
For the Nine
Months Ended
September 30,
2010
$
|
Accumulated from
November 3, 2008
(date of inception)
to September 30,
2011
$
|
|
|
Revenue
|
–
|
–
|
–
|
–
|
–
|
|
Operating Expenses
|
|||||
|
Consulting fees
|
–
|
–
|
20,000
|
–
|
80,000
|
|
General and administrative
|
19,049
|
157
|
21,286
|
588
|
22,839
|
|
Management fees
|
5,000
|
7,500
|
20,000
|
17,500
|
43,727
|
|
Professional fees
|
9,556
|
9,000
|
35,556
|
40,000
|
99,106
|
|
Transfer agent fees
|
890
|
347
|
2,508
|
6,134
|
16,977
|
|
Loss Before Other Income (Expense)
|
(34,495)
|
(17,004)
|
(99,350)
|
(64,222)
|
(262,649)
|
|
Other Income (Expense)
|
|||||
|
Accretion expense
|
(1,342)
|
–
|
(1,342)
|
–
|
(1,342)
|
|
Gain on settlement of debt
|
240,268
|
–
|
240,268
|
–
|
240,268
|
|
Interest expense
|
(7,604)
|
(821)
|
(14,642)
|
(1,491)
|
(19,840)
|
|
231,322
|
(821)
|
224,284
|
(1,491)
|
219,086
|
|
|
Net Income (Loss) for the Period
|
196,827
|
(17,825)
|
124,934
|
(65,713)
|
(43,563)
|
|
Net Income (Loss) Per Share, Basic and Diluted
|
–
|
(0.01)
|
–
|
(0.05)
|
|
|
Weighted Average Shares Outstanding
|
442,790,000
|
1,455,000
|
505,348,205
|
1,439,780
|
|
For the Nine
Months Ended
September 30,
2011
$
|
For the Nine
Months Ended
September 30,
2010
$
|
Accumulated from
November 3, 2008
(date of inception)
to September 30,
2011
$
|
|
|
Operating Activities
|
|||
|
Net income (loss) for the period
|
124,934
|
(65,713)
|
(43,563)
|
|
Adjustment to reconcile net income (loss) to cash used in operating activities:
|
|||
|
Accretion expense
|
1,342
|
–
|
1,342
|
|
Gain on settlement of debt
|
(240,268)
|
–
|
(240,268)
|
|
Stock-based compensation
|
–
|
–
|
2,227
|
|
Shares issued for management fees
|
–
|
4,500
|
5,500
|
|
Shares issuable for settlement of services
|
–
|
6,000
|
1,500
|
|
Changes in operating assets and liabilities:
|
|||
|
Prepaid expense and deposits
|
(9,542)
|
–
|
(9,542)
|
|
Accounts payable and accrued liabilities
|
6,347
|
21,588
|
36,914
|
|
Accounts payable and accrued liabilities – related
|
4,007
|
4,007
|
|
|
Due to related parties
|
–
|
–
|
11,965
|
|
Net Cash Used in Operating Activities
|
(113,180)
|
(33,625)
|
(229,918)
|
|
Financing activities
|
|||
|
Proceeds from loan payable
|
710,600
|
139,600
|
850,200
|
|
Repayments of loan payable
|
(149,449)
|
–
|
(149,449)
|
|
Proceeds from related parties
|
–
|
–
|
2,649
|
|
Proceeds from the issuance of common stock
|
–
|
–
|
7,523
|
|
Net Cash Provided by Financing Activities
|
561,151
|
139,600
|
710,923
|
|
Increase (decrease) in Cash
|
447,971
|
105,975
|
481,005
|
|
Cash, Beginning of Period
|
33,034
|
11
|
–
|
|
Cash, End of Period
|
481,005
|
105,986
|
481,005
|
|
Supplemental Disclosures
|
|||
|
Interest paid
|
–
|
–
|
–
|
|
Income tax paid
|
–
|
–
|
–
|
|
Non-cash investing and financing activities
|
|||
|
Forgiveness of related party debt
|
–
|
2,649
|
2,649
|
|
Issuance of common shares for acquisition of assets
|
250,000
|
–
|
250,000
|
|
Issuance of preferred shares for acquisition of assets
|
7,500
|
–
|
7,500
|
|
Issuance of note payable for acquisition of assets
|
325,000
|
–
|
325,000
|
|
·
|
significant underperformance relative to historical or expected projected future operating results;
|
|
·
|
significant changes in the manner of our use of the acquired assets or the strategy for our overall business;
|
|
·
|
significant negative industry or economic trends;
|
|
·
|
significant decline in our stock price for a sustained period of time; and
|
|
·
|
our market capitalization relative to net book value.
|
|
Cost
$
|
Accumulated Depreciation
$
|
September 30,
2011
Net Carrying
Value
$
|
December 31,
2010
Net Carrying
Value
$
|
|
|
|
||||
|
License
|
82,538
|
–
|
82,538
|
–
|
|
|
||||
|
82,538
|
–
|
82,538
|
–
|
|
a)
|
As of August 12, 2011, the former President of the Company was owed $24,965 (2010 - $11,965) for management fees. The amount owing was unsecured, non-interest bearing and due on demand. On August 12, 2011, the Company repaid $10,000 and the former President of the Company forgave the outstanding amount owing of $14,965, which was recorded as a gain on settlement of debt.
|
|
b)
|
As at September 30, 2011, the Company owes $329,007, including accrued interest, (2010 - $nil) to HOEL, a company controlled by officers and directors of the Company. The amounts owing are unsecured, with a principal balance of $325,000 bearing interest of 10% per annum, and due by August 16, 2012. As of September 30, 2011, the Company has recorded accrued interest of $4,007.
|
|
c)
|
On August 16, 2011, Mr. Tassos D. Recachinas (“Mr. Recachinas was appointed as the President and Director of the Company. Mr. Recachinas is an officer, director and indirectly the controlling shareholder of Hillwinds Ocean Energy, LLC (“HOEL”), a privately-held carbon capture, carbon sequestration and algae-for-biofuels technology company. Following the execution of the Acquisition Agreement, HOEL became the beneficial owner of a majority of the common stock of the Company, and the owner of all of the preferred stock of the Company, making Mr. Recachinas a controlling shareholder of the Company. HOEL became the majority owner of shares of the Company’s common stock and the owner of 100% of the Company’s issued and outstanding preferred stock.
|
|
d)
|
On August 16, 2011, the Company executed an unsecured promissory note (the "Note") to HOEL. Under the terms of the Note, the Company promises to pay to the order of HOEL, the principal amount of three hundred twenty five thousand dollars ($325,000), with simple interest accruing at an annual rate of ten percent (10%) thereon. The Note is due on or before August 16, 2012. The Note also contains customary events of default.
|
|
a)
|
In April 2010, Company issued a demand note to a non-related party for $34,600. Under the terms of the note, the amount owing was unsecured, due at 10% per annum, and due on demand. On August 11, 2011, the Company repaid $39,187, comprised of principal payments of $34,600 and accrued interest of $4,587, retiring the note.
|
|
b)
|
On September 28, 2010, the Company issued a demand note to a non-related party for $105,000. Under the terms of the note, the amount owing was unsecured, due interest of 10% per annum, and due on or before September 28, 2011. On August 11, 2011, the Company repaid $114,177 comprised of principal payments of $105,000 and accrued interest of $9,177, retiring the note.
|
|
c)
|
On June 20, 2011, the Company issued a demand note to a non-related party for $10,000 (2010 - $nil). Under the terms of the note, the amount owing was unsecured, due interest at 10% per annum, and due on demand. On July 27, 2011, the Company repaid $10,000. As of August 11, 2011, accrued interest of $151 was recorded in accrued liabilities. On August 11, 2011, the non-related party forgave the accrued interest of $151, which was recorded as a gain on settlement of debt, and the note was retired.
|
|
d)
|
In August 2011, the Company issued a note payable for proceeds of $200,600. Under the terms of the notes, the amounts owing were unsecured, due interest of 10% per annum, and due on demand. On August 12, 2011, the Company recorded accrued interest of $151, and the note was forgiven resulting in a gain on settlement of debt of $200,751.
|
|
e)
|
In August 2011, the Company issued a draw down convertible promissory note to a non-related party for $500,000, comprised of three payments of $100,000 on August 19, 2011, $150,000 on August 26, 2011, and $250,000 on September 6, 2011. Under the terms of the note, the amount owing is unsecured, due interest of 3% per annum, and due on or before February 19, 2013. As at September 30, 2011, accrued interest of $1,767 has been recorded in accrued liabilities.
|
|
|
a)
|
On March 9, 2011, the Company and its Board of Directors approved a thirty-to-one (30:1) forward stock split of all issued and outstanding common shares. The effect of the forward stock split increased the number of issued and outstanding common shares from 1,495,000 shares to 44,850,000 shares, and the forward stock split has been applied on a retroactive basis since the Company’s inception date.
|
|
|
b)
|
On June 6, 2011, the Company and its Board of Directors approved the increase of the number of authorized common shares to 550,000,000 common shares and 50,000,000 preferred shares (of which 25,000,000 were designated as Series A Preferred Stock) as well as a twelve-to-one (12:1) forward stock split of all issued and outstanding common shares. The effect of the forward stock split increased the number of issued and outstanding common shares from 44,850,000 shares to 538,200,000 shares, and the forward stock split has been applied on a retroactive basis since the Company’s inception date.
|
|
|
c)
|
On August 15, 2011, the Company and its Board of Directors approved the increase of the number of authorized common shares to 2,000,000,000. The number of issued and outstanding common shares was unchanged and remained at 438,200,000 shares.
|
|
|
d)
|
On August 15, 2011, the former Chief Executive Officer and Director of the Company returned 440,820,000 common shares to treasury, and the shares were effectively cancelled.
|
|
|
e)
|
On August 15, 2011, the Company issued 250,000,000 common shares of the Company and 7,500,000 Class A preferred shares of the Company as part of the acquisition of the license, as disclosed in Note 3.
|
|
September 30,
|
December 31,
|
|
|
|
2011
|
2010
|
|
|
$
|
$
|
|
Current Assets
|
490,547
|
33,034
|
|
Current Liabilities
|
338,369
|
182,132
|
|
Working Capital (Deficit)
|
152,178
|
(149,098)
|
|
Nine months ended
|
Nine months ended
|
|
|
September 30,
|
September 30,
|
|
|
2011
|
2010
|
|
|
|
$
|
$
|
|
Cash Flows from (used in) Operating Activities
|
(113,180)
|
(33,625)
|
|
Cash Flows from (used in) Financing Activities
|
561,151
|
139,600
|
|
Net Increase (decrease) in Cash During Period
|
447,971
|
105,975
|
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
X
|
|||
|
10.15
|
Draw Down Convertible Promissory Note.
|
X
|
|||
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
|
HDS INTERNATIONAL CORP.
|
||
|
BY:
|
TASSOS RECACHINAS
|
|
|
Tassos Recachinas
|
||
|
President
|
||
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
X
|
|||
|
10.15
|
Draw Down Convertible Promissory Note.
|
X
|
|||
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|